US Stock MarketDetailed Quotes
GLMD Galmed Pharmaceuticals
- 0.3641
- -0.0087-2.33%
Close Apr 22 16:00 ET
- 0.3693
- +0.0052+1.43%
Post 19:05 ET
2.19MMarket Cap-145P/E (TTM)
0.3728High0.3521Low64.30KVolume0.3660Open0.3728Pre Close23.15KTurnover1.84%Turnover RatioLossP/E (Static)6.01MShares7.800052wk High0.16P/B1.28MFloat Cap0.260052wk Low--Dividend TTM3.51MShs Float405.9000Historical High--Div YieldTTM5.55%Amplitude0.2600Historical Low0.3590Avg Price1Lot Size
Galmed Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -8.29%12.64M | -8.29%12.64M | -30.71%13.31M | -58.35%9.33M | -57.72%12.15M | -60.40%13.79M | -60.40%13.79M | -54.15%19.21M | -56.13%22.4M | -51.12%28.74M |
| -Cash and cash equivalents | 41.91%2.86M | 41.91%2.86M | -63.51%1.48M | -49.04%1.01M | -55.31%1.67M | -30.10%2.02M | -30.10%2.02M | 16.36%4.06M | -75.01%1.98M | -72.05%3.74M |
| -Short-term investments | -16.89%9.78M | -16.89%9.78M | -21.92%11.83M | -59.25%8.32M | -58.08%10.48M | -63.14%11.77M | -63.14%11.77M | -60.56%15.15M | -52.66%20.42M | -44.96%25M |
| Receivables | 5.10%165K | 5.10%165K | -33.10%770K | -44.46%341K | -32.62%568K | 98.73%157K | 98.73%157K | -31.24%1.15M | 26.08%614K | 7.53%843K |
| -Other receivables | 5.10%165K | 5.10%165K | -33.10%770K | -44.46%341K | -32.62%568K | 98.73%157K | 98.73%157K | -31.24%1.15M | 26.08%614K | 7.53%843K |
| Prepaid assets | -52.84%315K | -52.84%315K | ---- | ---- | ---- | -36.14%668K | -36.14%668K | ---- | ---- | ---- |
| Restricted cash | 2.63%117K | 2.63%117K | 0.88%115K | 0.88%115K | 0.00%114K | 0.00%114K | 0.00%114K | 0.88%114K | 0.88%114K | 0.88%114K |
| Total current assets | -10.09%13.24M | -10.09%13.24M | -30.67%14.2M | -57.69%9.79M | -56.79%12.83M | -59.16%14.72M | -59.16%14.72M | -53.13%20.48M | -55.23%23.13M | -50.25%29.7M |
| Non current assets | ||||||||||
| Net PPE | -62.91%125K | -62.91%125K | -55.24%175K | -49.21%226K | -43.46%281K | -38.84%337K | -38.84%337K | -35.48%391K | -32.58%445K | -26.37%497K |
| -Gross PPE | -13.66%1.14M | -13.66%1.14M | -55.24%175K | -49.21%226K | -43.46%281K | -12.14%1.33M | -12.14%1.33M | -35.48%391K | -32.58%445K | -26.37%497K |
| -Accumulated depreciation | -3.14%-1.02M | -3.14%-1.02M | ---- | ---- | ---- | -3.24%-988K | -3.24%-988K | ---- | ---- | ---- |
| Investments and advances | 117.67%3.27M | 117.67%3.27M | --3.27M | --3.27M | --1.68M | --1.5M | --1.5M | ---- | ---- | ---- |
| Total non current assets | 84.54%3.39M | 84.54%3.39M | 779.80%3.44M | 684.49%3.49M | 293.76%1.96M | 233.39%1.84M | 233.39%1.84M | -35.48%391K | -32.58%445K | -26.37%497K |
| Total assets | 0.41%16.63M | 0.41%16.63M | -15.48%17.64M | -43.68%13.28M | -51.02%14.79M | -54.76%16.56M | -54.76%16.56M | -52.89%20.87M | -54.95%23.58M | -49.99%30.2M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -26.80%1.88M | -26.80%1.88M | -58.44%2.09M | -0.22%2.72M | -50.40%2.8M | -56.34%2.57M | -56.34%2.57M | -20.75%5.03M | -61.06%2.73M | -20.88%5.65M |
| -accounts payable | -26.60%1.88M | -26.60%1.88M | -68.96%1.47M | 2.44%2.14M | -53.13%2.27M | -47.44%2.56M | -47.44%2.56M | -9.25%4.75M | -62.89%2.09M | -16.68%4.84M |
| -Other payable | ---- | ---- | 118.79%617K | -8.91%583K | -34.11%535K | -99.31%7K | -99.31%7K | -74.71%282K | -53.59%640K | -39.13%812K |
| Current accrued expenses | 32.14%259K | 32.14%259K | ---- | ---- | ---- | --196K | --196K | ---- | ---- | ---- |
| Current debt and capital lease obligation | -76.02%41K | -76.02%41K | ---- | ---- | ---- | --171K | --171K | ---- | ---- | ---- |
| -Current capital lease obligation | -76.02%41K | -76.02%41K | ---- | ---- | ---- | --171K | --171K | ---- | ---- | ---- |
| Current liabilities | -11.12%2.75M | -11.12%2.75M | -58.44%2.09M | -0.22%2.72M | -50.40%2.8M | -47.37%3.09M | -47.37%3.09M | -20.75%5.03M | -61.06%2.73M | -20.88%5.65M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | --0 | --0 | --0 | --0 | --0 | -80.79%44K | -80.79%44K | -67.52%89K | -57.86%134K | -35.34%183K |
| -Long term capital lease obligation | --0 | --0 | --0 | --0 | --0 | -80.79%44K | -80.79%44K | -67.52%89K | -57.86%134K | -35.34%183K |
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | -80.79%44K | -80.79%44K | -67.52%89K | -57.86%134K | -35.34%183K |
| Total liabilities | -12.36%2.75M | -12.36%2.75M | -59.16%2.09M | -4.89%2.72M | -51.96%2.8M | -48.62%3.14M | -48.62%3.14M | -22.68%5.12M | -60.92%2.86M | -21.43%5.83M |
| Shareholders'equity | ||||||||||
| Share capital | 198.57%209K | 198.57%209K | 137.14%166K | 0.00%70K | 0.00%70K | 0.00%70K | 0.00%70K | 0.00%70K | 0.00%70K | 0.00%70K |
| -common stock | 198.57%209K | 198.57%209K | 137.14%166K | 0.00%70K | 0.00%70K | 0.00%70K | 0.00%70K | 0.00%70K | 0.00%70K | 0.00%70K |
| Retained earnings | -3.72%-192.95M | -3.72%-192.95M | -4.11%-190.94M | -6.41%-189.46M | -7.77%-187.87M | -10.62%-186.04M | -10.62%-186.04M | -14.11%-183.4M | -16.37%-178.05M | -20.54%-174.32M |
| Paid-in capital | 3.47%207.08M | 3.47%207.08M | 3.48%206.92M | 0.47%200.61M | 0.61%200.44M | 0.69%200.14M | 0.69%200.14M | 0.78%199.96M | 0.93%199.68M | 0.95%199.23M |
| Gains losses not affecting retained earnings | 39.06%-454K | 39.06%-454K | 30.71%-607K | 32.59%-662K | -4.71%-645K | -335.67%-745K | -335.67%-745K | -1,068.00%-876K | -1,009.26%-982K | -533.80%-616K |
| Total stockholders'equity | 3.40%13.88M | 3.40%13.88M | -1.28%15.55M | -49.04%10.55M | -50.79%11.99M | -55.99%13.42M | -55.99%13.42M | -58.20%15.75M | -53.97%20.71M | -53.99%24.37M |
| Total equity | 3.40%13.88M | 3.40%13.88M | -1.28%15.55M | -49.04%10.55M | -50.79%11.99M | -55.99%13.42M | -55.99%13.42M | -58.20%15.75M | -53.97%20.71M | -53.99%24.37M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg